2021

Professional development Vacancies
2021
VigiBase database signal (Uppsala Monitoring Centre): Amiodarone, rivaroxoban and gastrointestinal bleeding – a drug interaction signal

During a check of the WHO Global Database, VigiBase, a signal was detected regarding the occurrence of gastrointestinal bleeding with the concomitant use of medicinal…

Read more
Health Canada has issued recommendations on the use of nonsteroidal anti-inflammatory drugs after week 20 of pregnancy and the risk of kidney damage in unborn children

Summary Medicinal products: Nonsteroidal anti-inflammatory drugs (NSAIDs), prescription and over-the-counter. Issue: Use of NSAIDs starting from the 20th…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing azathioprine (azathioprine)

The PRAC reviewed the available evidence from the EudraVigilance database, the literature, and information provided by registration certificate holders of medicinal products (Novartis, Aspen, and…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing naftifine (naftifine)

The Pharmacovigilance Risk Assessment Committee (PRAC), based on the analysis of Periodic Safety Update Reports (PSURs) for medicinal products containing…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing rosuvastatin/ezetimibe (rosuvastatin/ezetimibe)

The Pharmacovigilance Risk Assessment Committee (PRAC), based on the analysis of Periodic Safety Update Reports (PSURs) for medicinal products containing…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing irinotecan (Irinotecan)

The Pharmacovigilance Risk Assessment Committee (PRAC), based on the analysis of Periodic Safety Update Reports (PSURs) for medicinal products containing…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing iopromide

The Pharmacovigilance Risk Assessment Committee (PRAC), based on the analysis of Periodic Safety Update Reports (PSURs) for medicinal products containing…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing teicoplanin (teicoplanin)

Taking into account the Report of the Pharmacovigilance Risk Assessment Committee (PRAC) on medicinal products containing teicoplanin based on…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing tamoxifen (tamoxifen)

The Pharmacovigilance Risk Assessment Committee (PRAC), based on the analysis of Periodic Safety Update Reports (PSURs) for medicinal products containing…

Read more
LEVOFLOXACIN_MOXIFLOXACIN_CIPROFLOXACIN-PrJSC Technolog

Letter of the manufacturer PrJSC “Technolog” addressed to medical and pharmaceutical professionals and consumers regarding new data on the risk of heart valve regurgitation/insufficiency with the use of systemic and inhaled fluoroquinolones, with recommendations on the benefit/risk assessment and the procedure for reporting adverse reactions. compiled automatically

Read more